{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T04:03:18Z","timestamp":1788926598086,"version":"build-2803163510"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s11060-025-05402-5","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T11:15:49Z","timestamp":1767784549000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Risk of intracranial meningioma requiring surgical intervention among recent hormonal contraceptives users"],"prefix":"10.1007","volume":"176","author":[{"given":"Si","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Jugl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsey","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick J.","family":"Antonelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley","family":"Bruggeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Almut G.","family":"Winterstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,7]]},"reference":[{"issue":"suppl 4","key":"5402_CR1","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/nov189","volume":"17","author":"QT Ostrom","year":"2015","unstructured":"Ostrom QT, Gittleman H, Fulop J et al (2015) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the united States in 2008\u20132012. Neuro Oncol 17(suppl 4):iv1\u2013iv62. https:\/\/doi.org\/10.1093\/neuonc\/nov189","journal-title":"Neuro Oncol"},{"issue":"3","key":"5402_CR2","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1002\/cncr.22764","volume":"110","author":"EB Claus","year":"2007","unstructured":"Claus EB, Black PM, Bondy ML et al (2007) Exogenous hormone use and meningioma risk: what do we tell our patients? Cancer 110(3):471\u2013476. https:\/\/doi.org\/10.1002\/cncr.22764","journal-title":"Cancer"},{"issue":"6","key":"5402_CR3","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1227\/01.NEU.0000183924.03226.AA","volume":"57","author":"EB Claus","year":"2005","unstructured":"Claus EB, Bondy ML, Schildkraut JM et al (2005) Epidemiology of intracranial meningioma. Neurosurgery 57(6):1088\u20131095. https:\/\/doi.org\/10.1227\/01.NEU.0000183924.03226.AA","journal-title":"Neurosurgery"},{"issue":"2","key":"5402_CR4","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s11060-017-2664-5","volume":"136","author":"TA Harland","year":"2018","unstructured":"Harland TA, Freeman JL, Davern M et al (2018) Progesterone-only contraception is associated with a shorter progression-free survival in premenopausal women with WHO grade I meningioma. J Neurooncol 136(2):327\u2013333. https:\/\/doi.org\/10.1007\/s11060-017-2664-5","journal-title":"J Neurooncol"},{"key":"5402_CR5","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/1471-2407-6-152","volume":"6","author":"B Custer","year":"2006","unstructured":"Custer B, Longstreth WT Jr, Phillips LE et al (2006) Hormonal exposures and the risk of intracranial meningioma in women: a population-based case-control study. BMC Cancer 6:152. https:\/\/doi.org\/10.1186\/1471-2407-6-152","journal-title":"BMC Cancer"},{"issue":"12","key":"5402_CR6","doi-asserted-by":"publisher","first-page":"e83261","DOI":"10.1371\/journal.pone.0083261","volume":"8","author":"ZY Qi","year":"2013","unstructured":"Qi ZY, Shao C, Huang YL et al (2013) Reproductive and exogenous hormone factors in relation to risk of meningioma in women: a meta-analysis. PLoS ONE 8(12):e83261. https:\/\/doi.org\/10.1371\/journal.pone.0083261","journal-title":"PLoS ONE"},{"issue":"8","key":"5402_CR7","first-page":"1839","volume":"62","author":"BS Apgar","year":"2000","unstructured":"Apgar BS, Greenberg G (2000) Using progestins in clinical practice. Am Fam Physician 62(8):1839\u20131846","journal-title":"Am Fam Physician"},{"issue":"2 Pt 1","key":"5402_CR8","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1097\/AOG.0b013e31829d2549","volume":"122","author":"RP Urrutia","year":"2013","unstructured":"Urrutia RP, Coeytaux RR, McBroom AJ et al (2013) Risk of acute thromboembolic events with oral contraceptive use: a systematic review and meta-analysis. Obstet Gynecol 122(2 Pt 1):380\u2013389. https:\/\/doi.org\/10.1097\/AOG.0b013e31829d2549","journal-title":"Obstet Gynecol"},{"issue":"1","key":"5402_CR9","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/j.1440-1789.2009.01041.x","volume":"30","author":"CG Le\u00e3es","year":"2010","unstructured":"Le\u00e3es CG, Meurer RT, Coutinho LB et al (2010) Immunohistochemical expression of aromatase and estrogen, androgen and progesterone receptors in normal and neoplastic human meningeal cells. Neuropathology 30(1):44\u201349. https:\/\/doi.org\/10.1111\/j.1440-1789.2009.01041.x","journal-title":"Neuropathology"},{"issue":"2","key":"5402_CR10","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3171\/jns.1994.81.2.0184","volume":"81","author":"AB Rubinstein","year":"1994","unstructured":"Rubinstein AB, Loven D, Geier A, Reichenthal E, Gadoth N (1994) Hormone receptors in initially excised versus recurrent intracranial meningiomas. J Neurosurg 81(2):184\u2013187. https:\/\/doi.org\/10.3171\/jns.1994.81.2.0184","journal-title":"J Neurosurg"},{"issue":"9","key":"5402_CR11","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1158\/1055-9965.EPI-06-0227","volume":"15","author":"A Wigertz","year":"2006","unstructured":"Wigertz A, Lonn S, Hall P et al (2006) Long-term use of oral contraceptives and meningioma risk in women. Cancer Epidemiol Biomarkers Prev 15(9):1714\u20131717. https:\/\/doi.org\/10.1158\/1055-9965.EPI-06-0227","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"9","key":"5402_CR12","doi-asserted-by":"publisher","first-page":"e383","DOI":"10.1016\/S1470-2045(16)30334-X","volume":"17","author":"R Goldbrunner","year":"2016","unstructured":"Goldbrunner R, Minniti G, Preusser M et al (2016) EANO guidelines for the diagnosis and treatment of meningiomas. Lancet Oncol 17(9):e383\u2013e391. https:\/\/doi.org\/10.1016\/S1470-2045(16)30334-X","journal-title":"Lancet Oncol"},{"issue":"12","key":"5402_CR13","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/S0895-4356(96)00236-3","volume":"49","author":"P Peduzzi","year":"1996","unstructured":"Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR (1996) A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol 49(12):1373\u20131379. https:\/\/doi.org\/10.1016\/S0895-4356(96)00236-3","journal-title":"J Clin Epidemiol"},{"key":"5402_CR14","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.ebiom.2017.12.020","volume":"27","author":"HB Huttner","year":"2018","unstructured":"Huttner HB, Bergmann O, Salehpour M et al (2018) Meningioma growth dynamics assessed by radiocarbon retrospective birth dating. EBioMedicine 27:176\u2013181. https:\/\/doi.org\/10.1016\/j.ebiom.2017.12.020","journal-title":"EBioMedicine"},{"key":"5402_CR15","unstructured":"Branum AM, Jones J (2015) Trends in long-acting reversible contraception use among U.S. Women aged 15\u201344. NCHS Data Brief (188):1\u20138"},{"issue":"1","key":"5402_CR16","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1227\/00006123-199507000-00014","volume":"37","author":"RS Carroll","year":"1995","unstructured":"Carroll RS, Zhang J, Dashner K, Black PM (1995) Progesterone and glucocorticoid receptor activation in meningiomas. Neurosurgery 37(1):92\u201397. https:\/\/doi.org\/10.1227\/00006123-199507000-00014","journal-title":"Neurosurgery"},{"issue":"3","key":"5402_CR17","doi-asserted-by":"publisher","first-page":"527","DOI":"10.3171\/jns.1994.80.3.0527","volume":"80","author":"Y Matsuda","year":"1994","unstructured":"Matsuda Y, Kawamoto K, Kiya K, Kurisu K, Sugiyama K, Uozumi T (1994) Antitumor effects of antiprogesterones on human meningioma cells in vitro and in vivo. J Neurosurg 80(3):527\u2013534. https:\/\/doi.org\/10.3171\/jns.1994.80.3.0527","journal-title":"J Neurosurg"},{"issue":"1","key":"5402_CR18","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3171\/jns.1986.65.1.0099","volume":"65","author":"JJ Olson","year":"1986","unstructured":"Olson JJ, Beck DW, Schlechte J et al (1986) Hormonal manipulation of meningiomas in vitro. J Neurosurg 65(1):99\u2013107. https:\/\/doi.org\/10.3171\/jns.1986.65.1.0099","journal-title":"J Neurosurg"},{"issue":"4","key":"5402_CR19","doi-asserted-by":"publisher","first-page":"584","DOI":"10.3171\/jns.1987.66.4.0584","volume":"66","author":"JJ Olson","year":"1987","unstructured":"Olson JJ, Beck DW, Schlechte JA et al (1987) Effect of the antiprogesterone RU-38486 on meningioma implanted into nude mice. J Neurosurg 66(4):584\u2013587. https:\/\/doi.org\/10.3171\/jns.1987.66.4.0584","journal-title":"J Neurosurg"},{"issue":"8","key":"5402_CR20","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1080\/07357900600936312","volume":"24","author":"SM Grunberg","year":"2006","unstructured":"Grunberg SM, Weiss MH, Russell CA et al (2006) Long-term administration of mifepristone (RU486): clinical tolerance during extended treatment of meningioma. Cancer Invest 24(8):727\u2013733. https:\/\/doi.org\/10.1080\/07357900600936312","journal-title":"Cancer Invest"},{"issue":"34","key":"5402_CR21","doi-asserted-by":"publisher","first-page":"4093","DOI":"10.1200\/JCO.2015.62.1540","volume":"33","author":"YL Ji","year":"2015","unstructured":"Ji YL, Rankin C, Grunberg S et al (2015) Double-blind phase III randomized trial of the antiprogestin agent mifepristone in the treatment of unresectable meningioma: SWOG S9005. J Clin Oncol 33(34):4093\u20134098. https:\/\/doi.org\/10.1200\/JCO.2015.62.1540","journal-title":"J Clin Oncol"},{"issue":"1","key":"5402_CR22","doi-asserted-by":"publisher","first-page":"vdz003","DOI":"10.1093\/noajnl\/vdz003","volume":"1","author":"S Portet","year":"2019","unstructured":"Portet S, Naoufal R, Tachon G et al (2019) Histomolecular characterization of intracranial meningiomas developed in patients exposed to high-dose cyproterone acetate: an antiandrogen treatment. Neurooncol Adv 1(1):vdz003. https:\/\/doi.org\/10.1093\/noajnl\/vdz003","journal-title":"Neurooncol Adv"},{"issue":"3","key":"5402_CR23","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1093\/annonc\/mdx763","volume":"29","author":"M Peyre","year":"2018","unstructured":"Peyre M, Gaillard S, de Marcellus C et al (2018) Progestin-associated shift of meningioma mutational landscape. Ann Oncol 29(3):681\u2013686. https:\/\/doi.org\/10.1093\/annonc\/mdx763","journal-title":"Ann Oncol"},{"issue":"8","key":"5402_CR24","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.3174\/ajnr.A2076","volume":"31","author":"AM Gon\u00e7alves","year":"2010","unstructured":"Gon\u00e7alves AM, Page P, Domigo V, M\u00e9der JF, Oppenheim C (2010) Abrupt regression of a meningioma after discontinuation of cyproterone treatment. AJNR Am J Neuroradiol 31(8):1504\u20131505. https:\/\/doi.org\/10.3174\/ajnr.A2076","journal-title":"AJNR Am J Neuroradiol"},{"issue":"10","key":"5402_CR25","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1007\/s00701-015-2518-7","volume":"157","author":"AL Bernat","year":"2015","unstructured":"Bernat AL, Oyama K, Hamdi S et al (2015) Growth stabilization and regression of meningiomas after discontinuation of cyproterone acetate: a case series of 12 patients. Acta Neurochir (Wien) 157(10):1741\u20131746. https:\/\/doi.org\/10.1007\/s00701-015-2518-7","journal-title":"Acta Neurochir (Wien)"},{"issue":"3","key":"5402_CR26","doi-asserted-by":"publisher","first-page":"355","DOI":"10.4103\/jovr.jovr_59_18","volume":"13","author":"AL Bernat","year":"2018","unstructured":"Bernat AL, Bonnin S, Labidi M et al (2018) Regression of giant olfactory groove meningioma and complete visual acuity recovery after discontinuation of cyproterone acetate. J Ophthalmic Vis Res 13(3):355\u2013358. https:\/\/doi.org\/10.4103\/jovr.jovr_59_18","journal-title":"J Ophthalmic Vis Res"},{"issue":"4","key":"5402_CR27","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/s00701-018-03894-z","volume":"161","author":"T Passeri","year":"2019","unstructured":"Passeri T, Champagne PO, Bernat AL et al (2019) Spontaneous regression of meningiomas after interruption of nomegestrol acetate: a series of three patients. Acta Neurochir (Wien) 161(4):761\u2013765. https:\/\/doi.org\/10.1007\/s00701-018-03894-z","journal-title":"Acta Neurochir (Wien)"},{"key":"5402_CR28","doi-asserted-by":"publisher","first-page":"n37","DOI":"10.1136\/bmj.n37","volume":"372","author":"A Weill","year":"2021","unstructured":"Weill A, Nguyen P, Labidi M et al (2021) Use of high dose cyproterone acetate and risk of intracranial meningioma in women: cohort study. BMJ 372:n37. https:\/\/doi.org\/10.1136\/bmj.n37","journal-title":"BMJ"},{"key":"5402_CR29","doi-asserted-by":"publisher","first-page":"e078078","DOI":"10.1136\/bmj-2023-078078","volume":"384","author":"N Roland","year":"2024","unstructured":"Roland N, Neumann A, Hoisnard L et al (2024) Use of progestogens and the risk of intracranial meningioma: National case-control study. BMJ 384:e078078. https:\/\/doi.org\/10.1136\/bmj-2023-078078","journal-title":"BMJ"},{"issue":"5","key":"5402_CR30","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1093\/humupd\/dmw014","volume":"22","author":"V De Leo","year":"2016","unstructured":"De Leo V, Musacchio MC, Cappelli V, Piomboni P, Morgante G (2016) Hormonal contraceptives: Pharmacology tailored to women\u2019s health. Hum Reprod Update 22(5):634\u2013646. https:\/\/doi.org\/10.1093\/humupd\/dmw014","journal-title":"Hum Reprod Update"},{"issue":"1","key":"5402_CR31","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.contraception.2013.07.003","volume":"89","author":"V Halpern","year":"2014","unstructured":"Halpern V, Combes SL, Dorflinger LJ, Weiner DH, Archer DF (2014) Pharmacokinetics of subcutaneous depot Medroxyprogesterone acetate injected in the upper arm. Contraception 89(1):31\u201335. https:\/\/doi.org\/10.1016\/j.contraception.2013.07.003","journal-title":"Contraception"},{"issue":"6","key":"5402_CR32","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1016\/j.fertnstert.2014.01.024","volume":"101","author":"D Apter","year":"2014","unstructured":"Apter D, Gemzell-Danielsson K, Hauck B, Rosen K, Zurth C (2014) Pharmacokinetics of two low-dose levonorgestrel-releasing intrauterine systems and effects on ovulation rate and cervical function: pooled analyses of phase II and III studies. Fertil Steril 101(6):1656\u20131662. https:\/\/doi.org\/10.1016\/j.fertnstert.2014.01.024","journal-title":"Fertil Steril"},{"issue":"Suppl 1","key":"5402_CR33","doi-asserted-by":"publisher","first-page":"i5","DOI":"10.1093\/noajnl\/vdad020","volume":"5","author":"KM Walsh","year":"2023","unstructured":"Walsh KM, Price M, Neff C, Komisarow JM, Wimberly CE, Kruchko C, Barnholtz-Sloan JS, Ostrom QT (2023) The joint impacts of sex and race\/ethnicity on incidence of grade 1 versus grades 2\u20133 meningioma across the lifespan. Neurooncol Adv 5(Suppl 1):i5\u2013i12. https:\/\/doi.org\/10.1093\/noajnl\/vdad020","journal-title":"Neurooncol Adv"},{"issue":"2","key":"5402_CR34","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1093\/jnci\/djae253","volume":"117","author":"KM Walsh","year":"2025","unstructured":"Walsh KM, Price M, Raleigh DR, Calabrese E, Kruchko C, Barnholtz-Sloan JS, Ostrom QT (2025) Grade-stratified meningioma risk among individuals who are non-Hispanic black and interactions with male sex. J Natl Cancer Inst 117(2):366\u2013374. https:\/\/doi.org\/10.1093\/jnci\/djae253","journal-title":"J Natl Cancer Inst"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-025-05402-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-025-05402-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-025-05402-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T11:47:26Z","timestamp":1769773646000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-025-05402-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5402"],"URL":"https:\/\/doi.org\/10.1007\/s11060-025-05402-5","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"26 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The University of Florida Institutional Review Board exempted this observational study from review because of the use of de-identified data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All patient data in this observational study has been de-identified.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All patient data in this observational study has been de-identified.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"156"}}